BCG vaccination of neonatal calves: Potential roles for innate immune cells in the induction of protective immunity

N. Siddiqui, S. Price, J. Hope

Research output: Contribution to journalArticlepeer-review

Abstract

Bovine tuberculosis is a disease of increasing incidence in the UK causing major economic losses and with significant impact on bovine and, potentially human health: the causative agent Mycobacterium bovis is a zoonotic pathogen. Neonatal vaccination with the attenuated M. bovis Bacille Calmette Guerin (BCG) vaccine confers a significant degree of protection in cattle, and is a widely used control strategy for human TB. The adaptive immune system is relatively immature in neonates and increased numbers of innate effector cells present in young animals and human infants may compensate for this, enabling effective immune responses to vaccination. Natural killer cells and subsets of gammadelta TCR(+) T lymphocytes secrete high levels of interferon gamma and can interact with antigen presenting cells to promote both innate and adaptive immune responses. These cell populations may be pivotal in determining immune bias following neonatal vaccination with BCG.
Original languageEnglish
Pages (from-to)219-226
Number of pages8
JournalComparative Immunology, Microbiology and Infectious Diseases
Volume35
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'BCG vaccination of neonatal calves: Potential roles for innate immune cells in the induction of protective immunity'. Together they form a unique fingerprint.

Cite this